Translumina - About the company
Translumina is a seed company based in Hechingen (Germany), founded in 2010. It operates as a Manufacturer of drug-eluting stents and cardiovascular devices. It produces drug-eluting stents, drug-eluting balloons, coronary balloons, and vascular accessories. The company operates advanced manufacturing facilities and is committed to delivering high-quality products. Its focus is on developing and providing innovative cardiovascular intervention technologies. The manufacturing processes adhere to rigorous international standards.. Translumina has raised an undisclosed amount in funding from Everstone Capital. The company has 27 active competitors, including 8 funded and 8 that have exited. Its top competitors include companies like Edwards Lifesciences, InspireMD and Peytant Solutions.
Company Details
{}
- Website
- translumina.com
- Social
- Email ID
- *****@translumina.de
- Phone Number
- +49 **********
- Registered Address
- Neue Rottenburger Straße 50 72379 Hechingen
Key Metrics
Founded Year
2010
Location
Hechingen, Germany
Stage
Seed
Latest Funding Round
Investors
Ranked
10th among 27 active competitors
Employee Count
360 as on May 31, 2025
Investment & Acquisitions
Similar Companies
Legal entities associated with Translumina
Translumina is associated with 6 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
EVERCURE HOLDINGS PTE. LTD. CIN: 201828854D , Singapore, Active | Aug 22, 2018 | - | - | |
Translumina Therapeutics Llp CIN: AAA-0435 , India, Active | Dec 01, 2009 | $46.8M (As on Mar 31, 2023) | 360 (As on May 31, 2025) | |
Translumina Gmbh CIN: B2609_HRB420859 , Germany, Active | - | - | ||
Translumina Gmbh CIN: HRB420859 , Germany, Active | Nov 22, 2000 | - | 46 (As on Dec 31, 2021) | |
Translumina GmbH CIN: 0802.539.792 , Belgium, Active | Jun 07, 2023 | - | - | - |
INTEGRIS MEDTECH LIMITED CIN: U85110DL2008PLC177230 , India, Active | Apr 25, 2008 | $82.2M (As on Mar 31, 2025) | 13 (As on Aug 01, 2025) |
Sign up to download Translumina's company profile
Translumina's funding and investors
Translumina has raised funding over 2 rounds. Its first funding round was on Aug 28, 2019. Its latest funding round was a Seed round on Dec 2024 for $*****. 1 investor participated in its latest round. Translumina has 3 institutional investors.
Here is the list of recent funding rounds of Translumina:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 2024 | 2652500 | Seed | 7642013 | 8540627 | 4178904 | 7793952 |
Aug 28, 2019 | 2521584 | Seed | 6701333 | 4234700 | 4545612 |
Access funding benchmarks and valuations. Sign up today!View details of Translumina's funding rounds and investors
Translumina's founders and board of directors
Founder? Claim ProfileTranslumina's Board of Directors
Translumina's board has 1 active member. Eric Kumpa Haigerloch is independent board member.Here is the list of Translumina's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
gldleym | Team | - | Past | 6y 8m |
Independent board member | - | Current | 2y 3m | |
usdjmbh | Independent board member | - | Past | 2y 6m |
wwyebfn | Independent board member | - | Past | 2y 9m |
fndhfcy | Independent board member | - | Past | 3y 6m |
Translumina's employee count trend
Translumina has 360 employees as of May 25. The total employee count is 1.0% lower than what it was in May 24. Here is Translumina's employee count trend over the years:
Uncover Translumina's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Translumina's Competitors and alternates
Top competitors of Translumina include Edwards Lifesciences, InspireMD and Peytant Solutions. Here is the list of Top 10 competitors of Translumina, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Edwards Lifesciences 1958, Irvine (United States), Public | Developer of medical devices for structural heart disease | - | 65/100 | |
2nd | InspireMD 2005, Boston (United States), Public | Stents integrated with a bio-stable mesh | $34M | 63/100 | |
3rd | Peytant Solutions 2008, Plymouth (United States), Seed | Developer of a regenerative medical device for the treatment of luminal diseases | $5.59M | - | 53/100 |
4th | Provider of stent graft endovascular solution for aortic aneurysms | $25M | 52/100 | ||
5th | Vesper Medical 2016, Wayne (United States), Acquired | Provider of venous stent system | $52.5M | 51/100 | |
6th |  STENTiT 2007, Eindhoven (Netherlands), Seed | Developer of regenerative stent for vascular disorders | $1.94M | 51/100 | |
7th | Bentley InnoMed 2012, Hechingen (Germany), Funding Raised | Manufacturer of implants and catheters for endovascular treatment of vascular diseases | - | 48/100 | |
8th | Biosensors International 1990, Singapore (Singapore), Acquired | Products for interventional cardiology and critical care procedures | - | 48/100 | |
9th | Gore Medical 1997, Flagstaff (United States), Unfunded | Medical solutions provider improving lives through transformative technologies and sustainable practices | - | - | 45/100 |
10th |  Translumina 2010, Hechingen (Germany), Seed | Manufacturer of drug-eluting stents and cardiovascular devices. It produces drug-eluting stents, drug-eluting balloons, coronary balloons, and vascular accessories. The company operates advanced manufacturing facilities and is committed to delivering high-quality products. Its focus is on developing and providing innovative cardiovascular intervention technologies. The manufacturing processes adhere to rigorous international standards. | - | 44/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Translumina's competitors? Click here to see the top ones
Translumina's Investments and acquisitions
Translumina has acquired 3 companies including Blue Medical, Lamed and Blue Medical. Translumina has not made any investments as of now.Here is the list of its acquisitions:
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jun 29, 2023 | Acquisition | 1998 | Helmond (Netherlands) | |
Jun 07, 2023 | Acquisition | 1989 | Oberhaching (Germany) | |
Feb 15, 2013 | Acquisition | 1998 | Helmond (Netherlands) |
Want to know more about where corporates are investing? Sign up today!News related to Translumina
Filter this listMedia has covered Translumina for 1 event in last 1 year.
•
•
Everstone-backed Translumina hires former Medanta exec as CFOVCCircle•Jan 27, 2025•Translumina, Medanta
•
•
•
Indian stent maker Translumina Therapeutics announces initiation of direct operations in UAEBioSpectrum Asia•Sep 23, 2024•Translumina
•
•
•
Medtech firm Translumina bolsters German presence with acquisition of Lamed GmbHBioSpectrum India•Jun 07, 2023•Translumina, Lamed
•
Translumina further strengthens senior management to take next phase of growthResponse•Oct 10, 2022•Translumina, , Biedermann
•
Translumina unveils dual-drug polymer-free coated stent in international marketsBioSpectrum India•Apr 19, 2022•Translumina
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Translumina
Explore our recently published companies
- AlterWise - Redmond based, Unfunded company
- alixiroflife - Los Angeles based, Unfunded company
- Firefly Psychology - United Kingdom based, Unfunded company
- Alianza de Alimentos - Peru based, 2014 founded, Unfunded company
- BeanWeb - Colombia based, Unfunded company
- Island Portfolio Services - United States based, 2017 founded, Unfunded company
